Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers - BioSpace

Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers  BioSpace

NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) and Vedanta Biosciences today announced a clinical trial ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2UC2FBJ